Mangrove Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$6.97M Buy
2021
Q4
$3M Sell
2021
Q3
$4.17M Buy
2021
Q2
$1.5M Buy